EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells

Rajashree Patnaik iD, Riah Varghese iD, Ahad Al-Kabani iD, Shirin Jannati, Yajnavalka Banerjee iD

Cells · 16.09.2025 · 14 (18) · 1451

DOI: 10.3390/cells14181451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 16.09.2025. Verfasst von Rajashree Patnaik und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Health Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health, Dubai 505055, United Ar…. Hauptthemen laut MEDLINE: Curcumin, Colorectal Neoplasms, Apoptosis, Receptor, PAR-2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MBRU, Mohammed bin Rashid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic inflammation drives colorectal cancer (CRC) progression, with PAR-2, a G-protein coupled receptor, linking extracellular inflammatory signals to tumor-promoting pathways via ERK1/2 phosphorylation, calcium mobilization, TNF-α upregulation, and apoptosis suppression. While curcumin has notable anti-inflammatory and anti-cancer properties, its effects on PAR-2 signaling in inflammation-driven CRC remain underexplored.

Objective

This study investigates how curcumin modulates PAR-2 expression and downstream oncogenic signaling in inflammation-driven CRC cells and explores its potential direct interaction with PAR-2 at the structural level.

Methods

HT 29 and Caco-2 CRC cell lines were exposed to lipopolysaccharide (LPS) to induce an inflammatory phenotype, followed by treatment with curcumin at 50 µM and 100 µM. PAR-2 and PAR-1 expression, along with downstream markers including ERK1/2, p-ERK, TNF-α, caspase-8, cleaved caspase-8, caspase-3, Bcl 2, and Bax, were analyzed by Western blot and quantitative PCR. Calcium mobilization was assessed using Fluo-4 dye-based fluorescence imaging. Apoptosis was quantified using MTT viability assays, AO/EtBr dual staining, and Annexin V/PI flow cytometry. In parallel, AlphaFold-predicted structural models of PAR-2 were used to perform molecular docking with curcumin using CB-Dock2, to identify potential binding pockets and assess binding energetics.

Results

Curcumin selectively downregulated PAR-2—but not PAR-1—at both transcript and protein levels in a dose-dependent manner. This downregulation was accompanied by suppression of ERK phosphorylation and calcium signaling, inhibition of TNF-α secretion, and reversal of the anti-apoptotic signaling axis (Bcl 2 downregulation and Bax and caspase-3/-8 upregulation). Functional assays confirmed enhanced apoptosis in curcumin-treated cells. Computational docking revealed a high-affinity binding interaction between curcumin and the transmembrane domain of PAR-2, supporting the hypothesis of direct G-Protein-Coupled Receptor (GPCR) modulation.

Conclusions

Our findings reveal that curcumin targets the PAR-2/ERK/TNF-α axis and reactivates apoptotic pathways in inflammation-driven CRC, establishing it as a potent, mechanistically validated candidate for therapeutic repurposing in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminColorectal NeoplasmsApoptosisReceptor, PAR-2CalciumInflammationMAP Kinase Signaling SystemHumansPhosphorylationHT29 CellsCaco-2 CellsMolecular Docking SimulationCell Line, TumorSignal Transduction

Stichwörter der Autor:innen

Caspase-8ERK phosphorylationGPCR modulationPAR-2 signalingTNF-αapoptosiscalcium mobilizationcolorectal cancercurcuminmolecular docking

Substanzen

CurcuminReceptor, PAR-2Calcium

Autor:innen und Institutionen

  • College of Medicine and Health Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health, Dubai 505055, United Arab Emirates.
  • Department of Basic Medical Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health, Dubai 505055, United Arab Emirates.

ORCID-Profile: Rajashree Patnaik, Riah Varghese, Ahad Al-Kabani, Yajnavalka Banerjee

Förderung

  • MBRU
  • Mohammed bin Rashid University

Zitieren

APA

Patnaik, R., Varghese, R., Al-Kabani, A., Jannati, S., & Banerjee, Y. (2025). Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells. Cells, 14(18), 1451. https://doi.org/10.3390/cells14181451

Vancouver

Patnaik R, Varghese R, Al-Kabani A, Jannati S, Banerjee Y. Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells. Cells. 2025;14(18):1451. doi:10.3390/cells14181451

BibTeX
@article{Patnaik2025,
  author = {Patnaik, Rajashree and Varghese, Riah and Al-Kabani, Ahad and Jannati, Shirin and Banerjee, Yajnavalka},
  title = {Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {18},
  pages = {1451},
  doi = {10.3390/cells14181451}
}
Kostenlos starten →